Skip to content

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Hantavirus Cruise Ship Quarantine
Health
May 12, 2026 Evan Vega

Hantavirus Outbreak on Cruise Ship Prompts 42-Day Quarantine for 18 Americans in Omaha and Atlanta Facilities

Eighteen Americans quarantined for 42 days in Omaha and Atlanta after Andes hantavirus outbreak on Dutch cruise ship MV Hondius caused three deaths.

Read More
US Cruise Health Chief Resigns
Health
May 10, 2026 Evan Vega

Top US Official Overseeing Cruise Ship Public Health Policy Steps Down Following Internal CDC Announcement

Luis Rodríguez retired as chief of the CDC’s Vessel Sanitation Program amid a hantavirus outbreak and recent staff cuts, the agency announced.

Read More
Monocyte Aging Depression Biomarker
Health
May 10, 2026 Evan Vega

Monocyte Aging Blood Test Shows Promise for Early Depression Detection in New Biomarker Study

A study of 440 women links accelerated monocyte aging to non-somatic depression symptoms, suggesting a potential early biomarker for mood-related depression.

Read More
Physicians Lawsuit Risk Increase
Health
May 10, 2026 Evan Vega

AMA Research Reveals 1 in 3 Physicians Face Lawsuit Risk, Driving Up Insurance Premiums Nationwide

A 2024 AMA report shows nearly one in three U.S. physicians face malpractice lawsuits, raising medical liability insurance premiums nationwide.

Read More
FDA reevaluates Ebvallo drug
Health
May 8, 2026 Evan Vega

FDA To Reconsider Rare Cancer Drug Ebvallo After Surprise Rejection

The FDA will reconsider Atara Biotherapeutics’ rare cancer drug Ebvallo after initially rejecting it due to manufacturing concerns.

Read More
Medicare MIPS Reform Bill
Health
May 8, 2026 Evan Vega

H.R. 8622 Introduced To Reform Medicare’s MIPS Program For Greater Physician Fairness

Representatives Miller-Meeks and Conaway introduced H.R. 8622 to reform Medicare’s MIPS by freezing thresholds, reducing penalties, and enhancing physician feedback.

Read More
Measles-blocking antibodies isolated
Health
May 8, 2026 Evan Vega

Scientists Isolate Potent Measles-Blocking Antibodies From Vaccinated Patient’s Blood Amid U.S. Resurgence

Scientists isolated potent measles-blocking antibodies from a vaccinated patient, showing preventive and treatment effects in rodent models amid U.S. resurgence.

Read More
Abdominal Tightening Affects Balance
Health
May 7, 2026 Evan Vega

Abdominal Muscle Tightening Linked to Brain Sway and Potential Health Risks in Study

A 2026 study found abdominal muscle contractions cause brain sway by altering blood flow and cerebrospinal fluid movement in mice.

Read More
Nature-Based Activities Enhance Mental Health
Health
May 7, 2026 Evan Vega

Nature-Based Group Activities Improve Mental Health in Care Home Residents

A UK study found nature-based group activities in care homes improve residents’ mental health by reducing stress, anxiety, and loneliness.

Read More
Nebraska Implements Medicaid Work
Health
May 5, 2026 Evan Vega

Nebraska Becomes First State to Implement Trump’s Medicaid Work Requirements, Sparking Protests

Nebraska became the first state to enforce Medicaid work requirements, mandating 80 hours monthly for able-bodied enrollees without dependents.

Read More
  • ← Previous
  • Next →
Copyright © 2026 DAILYZ HEALTH NEWS. Powered by ColorMag and WordPress.